140 related articles for article (PubMed ID: 2423832)
1. [Treatment of chronic recurring parotitis with the protease inhibitor aprotinin (trasylol)].
Maier H; Adler D
Laryngol Rhinol Otol (Stuttg); 1986 Apr; 65(4):191-4. PubMed ID: 2423832
[TBL] [Abstract][Full Text] [Related]
2. New concepts in the treatment of chronic recurrent parotitis.
Maier H; Adler D; Lenarz T; Müller-Esterl W
Arch Otorhinolaryngol; 1985; 242(3):321-8. PubMed ID: 2416305
[TBL] [Abstract][Full Text] [Related]
3. [Glandular kallikrein in chronic recurrent parotitis].
Maier H; Adler D; Menstell S; Lenarz T
Laryngol Rhinol Otol (Stuttg); 1984 Dec; 63(12):633-5. PubMed ID: 6569964
[TBL] [Abstract][Full Text] [Related]
4. [Possibilities for using proteolytic enzyme inhibitors in the overall treatment of acute nonepidemic parotitis].
Balon LR; Sakovich AA
Vestn Khir Im I I Grek; 1974 Aug; 113(8):53-5. PubMed ID: 4549145
[No Abstract] [Full Text] [Related]
5. The effects of aprotinin, a glandular kallikrein inhibitor, on renin release and urinary sodium excretion in mild essential hypertensives.
Madeddu P; Oppes M; Soro A; Dessi'-Fulgheri P; Glorioso N; Manunta F; Rubatti S; Rappelli A
Agents Actions Suppl; 1987; 22():373-80. PubMed ID: 2449054
[TBL] [Abstract][Full Text] [Related]
6. Salivary factors in children with recurrent parotitis. Part 2: Protein, albumin, amylase, IgA, lactoferrin lysozyme and kallikrein concentrations.
Ericson S; Sjöbäck I
Swed Dent J; 1996; 20(5):199-207. PubMed ID: 9000329
[TBL] [Abstract][Full Text] [Related]
7. [On the parallelism of the autodigestive enzyme process in the pancreas and parotid gland and its treatment with trasylol].
LANKENFELD F
Ther Ggw; 1962 Aug; 101():364-70. PubMed ID: 14462201
[No Abstract] [Full Text] [Related]
8. [Contribution to the etiology and pathogenesis of chronic recurring parotitis].
Donath K; Gundlach KK
Dtsch Zahnarztl Z; 1979 Jan; 34(1):45-9. PubMed ID: 283007
[TBL] [Abstract][Full Text] [Related]
9. [Clinical picture and possible causes of functional disorders of the parotid gland in radioiodine therapy of differentiated thyroid cancer].
Deeg M; Maier H; Bihl H; Adler D
Laryngol Rhinol Otol (Stuttg); 1988 Jul; 67(7):362-6. PubMed ID: 3210869
[TBL] [Abstract][Full Text] [Related]
10. [Occlusion therapy in chronic recurrent parotitis? A report of clinical experiences with the use of a fibrin glue-gentamycin mixture].
Laskawi R; Shröder J; Brauneis J
Laryngol Rhinol Otol (Stuttg); 1988 Jul; 67(7):367-8. PubMed ID: 2463449
[TBL] [Abstract][Full Text] [Related]
11. The efficacy of aprotinin in arterial switch operations in infants.
Murugesan C; Banakal SK; Garg R; Keshavamurthy S; Muralidhar K
Anesth Analg; 2008 Sep; 107(3):783-7. PubMed ID: 18713883
[TBL] [Abstract][Full Text] [Related]
12. Chronic parotitis.
Abai S; Mandel L
N Y State Dent J; 2003 Oct; 69(8):21-3. PubMed ID: 14621365
[TBL] [Abstract][Full Text] [Related]
13. Effect of radioactive iodine therapy on parotid gland function.
Maier H; Bihl H
Acta Otolaryngol; 1987; 103(3-4):318-24. PubMed ID: 3495094
[TBL] [Abstract][Full Text] [Related]
14. Intraductal tetracycline therapy for the treatment of chronic recurrent parotitis.
Bowling DM; Ferry G; Rauch SD; Goodman ML
Ear Nose Throat J; 1994 Apr; 73(4):262-74. PubMed ID: 8020425
[TBL] [Abstract][Full Text] [Related]
15. Reduction of myocardial reperfusion injury by aprotinin after regional ischemia and cardioplegic arrest.
Khan TA; Bianchi C; Voisine P; Feng J; Baker J; Hart M; Takahashi M; Stahl G; Sellke FW
J Thorac Cardiovasc Surg; 2004 Oct; 128(4):602-8. PubMed ID: 15457162
[TBL] [Abstract][Full Text] [Related]
16. The influence of protease inhibitor on the progress of bronchial asthma.
Szymaniec J; Potocka Z; Rogala E; Socha B
Arch Immunol Ther Exp (Warsz); 1979; 27(6):871-3. PubMed ID: 95090
[TBL] [Abstract][Full Text] [Related]
17. [Effectiveness of the use of trasylol in the complex therapy of patients with acute and chronic recurrent pancreatitis].
Asauliuk IK
Vrach Delo; 1967 Oct; 10():14-6. PubMed ID: 5306817
[No Abstract] [Full Text] [Related]
18. [Acute purulent parotitis as a sequela of alkylphosphate (E 605) poisoning].
Leuwer A; Weisser B; Siewert B; Vetter H; Düsing R
Laryngorhinootologie; 1990 Sep; 69(9):468-71. PubMed ID: 2242183
[TBL] [Abstract][Full Text] [Related]
19. Low doses of aprotinin in aortocoronary bypass surgery--advantages and disadvantages.
Golański R; Golański J; Chizyński K; Iwaszkiewicz A; Zasłonka J; Pietrucha T; Chrul S; Watała C
Med Sci Monit; 2000; 6(4):722-8. PubMed ID: 11208399
[TBL] [Abstract][Full Text] [Related]
20. Is yohimbine-induced increase in salivary secretion a kinin-dependent mechanism?
Bagheri H; Bompart G; Girolami JP; Montastruc JL; Montastruc P
Fundam Clin Pharmacol; 1992; 6(1):17-20. PubMed ID: 1372876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
